Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling

Completed

• Conditions: Inflammatory Bowel Diseases

• Registration Number: NCT01666717
• Lead Sponsor: KU Leuven

Brief Summary

The purpose of the study is to evaluate fecal metabolites profiles of Inflammatory Bowel Disease(IBD) patients versus healthy controls (HC).

Detailed Description

Not available

Study Timeline

• Study Start: 2008-08
• Study Completion: 2012-05
• Status Verified: 2012-08
• Study First Submitted: 2012-08-14
• Study First Submitted QC: 2012-08-15
• Study First Posted: 2012-08-16
• Last Update Submitted: 2012-08-16
• Last Update Posted: 2012-08-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 204

Inclusion Criteria

• Clinical diagnosis of IBD
• Age >18 years

Exclusion Criteria

• Use of antibiotics in the preceding month
• Intake of pre- or probiotics

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

KULeuven-UZLeuven; 🇧🇪 Leuven, Vlaams-Brabant, Belgium